Abstract
Replication and transcription activator (RTA) is a critical lytic protein encoded by Kaposi’s sarcoma-associated herpesvirus (KSHV). To prepare rabbit polyclonal antibody against RTA, three antigenic polypeptides of KSHV RTA were initially synthesized. The fragment of RTA was cloned into p3FlagBsd to construct the recombinant plasmid, pRTA-Flag. 293 T and EA.hy926 cells were transfected with pRTA-Flag to obtain RTA-Flag fusion protein, which was detected using anti-Flag antibody. Next, New Zealand white rabbits were immunized with keyhole limpet hemocyanin-conjugated peptides to generate polyclonal antibodies against RTA. Enzyme-linked immunosorbent assays were performed to characterize the polyclonal antibodies, and the titers of the polyclonal antibodies against RTA were greater than 1:11,000. Western blotting and immunofluorescence assay revealed that the prepared antibody reacted specifically with the RTA-Flag fusion protein as well as the native viral protein in KSHV-infected primary effusion lymphoma cells. Collectively, our work successfully constructed the recombinant expression vector, pRTA-Flag, and prepared the polyclonal antibody against RTA, which was valuable for investigating the biochemical and biological functions of the critical KSHV lytic gene.
Similar content being viewed by others
References
Boshoff C, Chang Y (2001) Kaposi’s sarcoma-associated herpesvirus: a new DNA tumor virus. Annu Rev Med 52:453–470
Bowser BS, Morris S, Song MJ, Sun R, Damania B (2006) Characterization of Kaposi’s sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta. Virology 348:309–327
Bucher MH, Evdokimov AG, Waugh DS (2002) Differential effects of short affinity tags on the crystallization of Pyrococcus furiosus maltodextrin-binding protein. Acta Crystallogr D Biol Crystallogr 58:392–397
Byun H, Gwack Y, Hwang S, Choe J (2002) Kaposi’s sarcoma-associated herpesvirus open reading frame (ORF) 50 transactivates K8 and ORF57 promoters via heterogeneous response elements. Mol Cell 14:185–191
Carroll KD, Khadim F, Spadavecchia S, Palmeri D, Lukac DM (2007) Direct interactions of Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed–early promoter and stimulating viral reactivation. J Virol 81:8451–8467
Chang H, Dittmer DP, Shin YC, Hong Y, Jung JU (2005) Role of Notch signal transduction in Kaposi’s sarcoma-associated herpesvirus gene expression. J Virol 79:14371–14382
Chang PJ, Shedd D, Gradoville L, Cho MS, Chen LW, Chang J, Miller G (2002) Open reading frame 50 protein of Kaposi’s sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. J Virol 76:3168–3178
Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma. Science 266:1865–1869
Chen J (2006) Serial analysis of binding elements for human transcription factors. Nat Protoc 1:1481–1493
Chen J, Ueda K, Sakakibara S, Okuno T, Yamanishi K (2000) Transcriptional regulation of the Kaposi’s sarcoma-associated herpesvirus viral interferon regulatory factor gene. J Virol 74:8623–8634
Deng H, Song MJ, Chu JT, Sun R (2002) Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus). J Virol 76:8252–8264
Deng H, Young A, Sun R (2000) Auto-activation of the Rta gene of human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus. J Gen Virol 81:3043–3048
Greene W, Kuhne K, Ye F, Chen J, Zhou F, Lei X, Gao SJ (2007) Molecular biology of KSHV in relation to AIDS-associated oncogenesis. Cancer Treat Res 133:69–127
Han Z, Swaminathan S (2006) Kaposi’s sarcoma-associated herpesvirus lytic gene ORF57 is essential for infectious virion production. J Virol 80:5251–5260
Jeong J, Papin J, Dittmer D (2001) Differential regulation of the overlapping Kaposi’s sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters. J Virol 75:1798–1807
Katano H, Sato Y, Itoh H, Sata T (2001) Expression of human herpesvirus 8 (HHV-8)-encoded immediate early protein, open reading frame 50, in HHV-8-associated diseases. J Hum Virol 4:96–102
Lee HR, Brulois K, Wong L, Jung JU (2012) Modulation of immune system by Kaposi’s sarcoma-associated herpesvirus: lessons from viral evasion strategies. Front Microbiol 3:44
Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU (2010) Immune evasion by Kaposi’s sarcoma-associated herpesvirus. Future Microbiol 5:1349–1365
Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D (2002) The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev 16:1977–1989
Lin X, Liang D, He Z, Deng Q, Robertson ES, Lan K (2011) miR-K12-7-5p encoded by Kaposi’s sarcoma-associated herpesvirus stabilizes the latent state by targeting viral ORF50/RTA. PLoS ONE 6:e16224
Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F (2005) Monoclonal versus polyclonal antibodies: distinguishing characteristics, applications, and information resources. ILAR J 46:258–268
Liu Y, Cao Y, Liang D, Gao Y, Xia T, Robertson ES, Lan K (2008) Kaposi’s sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element. Virology 380:264–275
Lukac DM, Kirshner JR, Ganem D (1999) Transcriptional activation by the product of open reading frame 50 of Kaposi’s sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73:9348–9361
Mercader M, Taddeo B, Panella JR, Chandran B, Nickoloff BJ, Foreman KE (2000) Induction of HHV-8 lytic cycle replication by inflammatory cytokines produced by HIV-1-infected T cells. Am J Pathol 156:1961–1971
Ponomarenko JV, Bourne PE (2007) Antibody–protein interactions: benchmark datasets and prediction tools evaluation. BMC Struct Biol 7:64
Qin Y, Liu Z, Zhang T, Wang Y, Li X, Wang J (2010) Generation and application of polyclonal antibody against replication and transcription activator of Kaposi’s sarcoma-associated herpesvirus. Appl Biochem Biotechnol 160:1217–1226
Ruan GP, Ma L, He XW, Meng MJ, Zhu Y, Zhou MQ, Hu ZM, Wang XN (2005) Efficient production, purification, and application of egg yolk antibodies against human HLA-A*0201 heavy chain and light chain (beta2m). Protein Expr Purif 44:45–51
Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS (1998) Transcription mapping of the Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol 72:1005–1012
Song MJ, Deng H, Sun R (2003) Comparative study of regulation of RTA-responsive genes in Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 77:9451–9462
Song MJ, Li X, Brown HJ, Sun R (2002) Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi’s sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 76:5000–5013
St Swierzko A, Kirikae T, Kirikae F, Hirata M, Cedzynski M, Ziolkowski A, Hirai Y, Kusumoto S, Yokochi T, Nakano M (2000) Biological activities of lipopolysaccharides of Proteus spp. and their interactions with polymyxin B and an 18-kDa cationic antimicrobial protein (CAP18)-derived peptide. J Med Microbiol 49:127–138
Staudt MR, Dittmer DP (2006) Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi’s sarcoma-associated herpesvirus. Virology 350:192–205
Sun R, Lin SF, Staskus K, Gradoville L, Grogan E, Haase A, Miller G (1999) Kinetics of Kaposi’s sarcoma-associated herpesvirus gene expression. J Virol 73:2232–2242
Trier NH, Hansen PR, Houen G (2012) Production and characterization of peptide antibodies. Methods 56:136–144
Ueda K, Ishikawa K, Nishimura K, Sakakibara S, Do E, Yamanishi K (2002) Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) replication and transcription factor activates the K9 (vIRF) gene through two distinct cis elements by a non-DNA-binding mechanism. J Virol 76:12044–12054
Wang S, Liu S, Wu M, Geng Y, Wood C (2001a) Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence. Arch Virol 146:1415–1426
Wang S, Liu S, Wu MH, Geng Y, Wood C (2001b) Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi’s sarcoma-associated herpesvirus in transcriptional activation. J Virol 75:11961–11973
Wang SE, Wu FY, Yu Y, Hayward GS (2003) CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi’s sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. J Virol 77(17):9590–9612
Wong EL, Damania B (2006) Transcriptional regulation of the Kaposi’s sarcoma-associated herpesvirus K15 gene. J Virol 80:1385–1392
Xue Y, Zhou F, Fu C, Xu Y, Yao X (2006) SUMOsp: a web server for sumoylation site prediction. Nucleic Acids Res 34:W254–W257
Yang Y, Wang B, Yang D, Lu M, Xu Y (2012) Prokaryotic expression of woodchuck cytotoxic T lymphocyte antigen 4 (wCTLA-4) and preparation of polyclonal antibody to wCTLA-4. Protein Expr Purif 81:181–185
Ye F, Lei X, Gao SJ (2011) Mechanisms of Kaposi’s sarcoma-associated herpesvirus latency and reactivation. Adv Virol 2011
Yu Y, Black JB, Goldsmith CS, Browning PJ, Bhalla K, Offermann MK (1999) Induction of human herpesvirus-8 DNA replication and transcription by butyrate and TPA in BCBL-1 cells. J Gen Virol 80(Pt 1):83–90
Zhang L, Chiu J, Lin JC (1998) Activation of human herpesvirus 8 (HHV-8) thymidine kinase (TK) TATAA-less promoter by HHV-8 ORF50 gene product is SP1 dependent. DNA Cell Biol 17:735–742
Ziegelbauer JM (2011) Functions of Kaposi’s sarcoma-associated herpesvirus microRNAs. Biochim Biophys Acta 1809:623–630
Acknowledgments
We are grateful to Dr. Shou-Jiang Gao (University of Southern California) for generously providing plasmid. This work was supported by grants from the Natural Science Youth Foundation of Jiangsu Province (BK20140908) and Science Development Foundation of Nanjing Medical University (2013NJMU007).
Conflict of interest disclosure
The authors declare no competing financial interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Qin Yan holds a PhD, Nanjing Medical University.
Rights and permissions
About this article
Cite this article
Fan, W., Tang, Q., Shen, C. et al. Preparation and characterization of polyclonal antibody against Kaposi’s sarcoma-associated herpesvirus lytic gene encoding RTA. Folia Microbiol 60, 473–481 (2015). https://doi.org/10.1007/s12223-015-0387-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12223-015-0387-x